19225250

Source:http://linkedlifedata.com/resource/pubmed/id/19225250

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0021368, umls-concept:C0030705, umls-concept:C0087111, umls-concept:C0360714, umls-concept:C0948265, umls-concept:C1280500
pubmed:issue	1
pubmed:dateCreated	2009-2-19
pubmed:abstractText	Inflammation plays an important role in the pathogenesis of metabolic syndrome (MS). We investigated the effect of fluvastatin treatment on inflammatory markers in patients with MS.
pubmed:language	tur
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9426239
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL, http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Monounsaturated, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Indoles, http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides, http://linkedlifedata.com/resource/pubmed/chemical/fluvastatin
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1016-5169
pubmed:author	pubmed-author:AktopZiyaettinZ, pubmed-author:Ali CetinerMehmetM, pubmed-author:AydinMustafaM, pubmed-author:DemirciErkanE, pubmed-author:Do?anSait MesutSM, pubmed-author:GingrichJohn BJB, pubmed-author:KaraaslanSibelS, pubmed-author:MadakHediyeH, pubmed-author:OnukTolgaT, pubmed-author:SayinMuhammet Ra?itMR, pubmed-author:YildirimNesligülN
pubmed:issnType	Print
pubmed:volume	37
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	26-34
pubmed:meshHeading	pubmed-meshheading:19225250-Antigens, CD, pubmed-meshheading:19225250-Biological Markers, pubmed-meshheading:19225250-C-Reactive Protein, pubmed-meshheading:19225250-Cholesterol, pubmed-meshheading:19225250-Cholesterol, LDL, pubmed-meshheading:19225250-Fatty Acids, Monounsaturated, pubmed-meshheading:19225250-Female, pubmed-meshheading:19225250-Flow Cytometry, pubmed-meshheading:19225250-Humans, pubmed-meshheading:19225250-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:19225250-Indoles, pubmed-meshheading:19225250-Inflammation, pubmed-meshheading:19225250-Insulin Resistance, pubmed-meshheading:19225250-Lymphocyte Count, pubmed-meshheading:19225250-Male, pubmed-meshheading:19225250-Metabolic Syndrome X, pubmed-meshheading:19225250-Middle Aged, pubmed-meshheading:19225250-Triglycerides
pubmed:year	2009
pubmed:articleTitle	[The effect of statin treatment on inflammation in patients with metabolic syndrome].
pubmed:affiliation	Zonguldak Karaelmas Universitesi, Tip Fakültesi Kardiyoloji Anabilim Dali, Zonguldak, Turkey. drmustafaaydin@hotmail.com
pubmed:publicationType	Journal Article, English Abstract